Union Bancaire Privee, Ubp Sa Biogen Inc. Transaction History
Union Bancaire Privee, Ubp Sa
- $4.81 Billion
- Q4 2024
A detailed history of Union Bancaire Privee, Ubp Sa transactions in Biogen Inc. stock. As of the latest transaction made, Union Bancaire Privee, Ubp Sa holds 82 shares of BIIB stock, worth $11,780. This represents 0.0% of its overall portfolio holdings.
Number of Shares
82Holding current value
$11,780% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BIIB
# of Institutions
1,010Shares Held
129MCall Options Held
1.12MPut Options Held
1.43M-
Vanguard Group Inc Valley Forge, PA16.7MShares$2.4 Billion0.06% of portfolio
-
Primecap Management CO Pasadena, CA16.3MShares$2.34 Billion2.37% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.09 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.34MShares$1.06 Billion0.06% of portfolio
-
Jpmorgan Chase & CO New York, NY5.26MShares$755 Million0.08% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $20.7B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...